Literature DB >> 18635972

Assessment of the validation of blood pressure monitors: a statistical reappraisal.

Bruce A Friedman1, Bruce S Alpert, David Osborn, L Michael Prisant, David E Quinn, John Seller.   

Abstract

Protocols to determine the accuracy of noninvasive blood pressure monitors have been published by the Association for the Advancement of Medical Instrumentation, the British Hypertension Society, and the European Society of Hypertension (ESH). We compared the statistical basis for each of these protocols. Although the Association for the Advancement of Medical Instrumentation and British Hypertension Society protocols require a minimum of 85 participants, the ESH protocol requires only 33 participants. The reduced sample size results in a reduction in statistical power from 98 to 70%, which brings into question the applicability of the ESH (International) protocol.

Entities:  

Mesh:

Year:  2008        PMID: 18635972     DOI: 10.1097/MBP.0b013e3283071a64

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  7 in total

Review 1.  Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation Studies.

Authors:  Natalie A Bello; Jonathan J Woolley; Kirsten Lawrence Cleary; Louise Falzon; Bruce S Alpert; Suzanne Oparil; Gary Cutter; Ronald Wapner; Paul Muntner; Alan T Tita; Daichi Shimbo
Journal:  Hypertension       Date:  2017-12-11       Impact factor: 10.190

2.  Regular use of a home blood pressure monitor by hypertensive adults--HealthStyles, 2005 and 2008.

Authors:  Carma Ayala; Xin Tong; Nora L Keenan
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-19       Impact factor: 3.738

3.  A Call to Regulate Manufacture and Marketing of Blood Pressure Devices and Cuffs: A Position Statement From the World Hypertension League, International Society of Hypertension and Supporting Hypertension Organizations.

Authors:  Norm R C Campbell; Mark Gelfer; George S Stergiou; Bruce S Alpert; Martin G Myers; Michael K Rakotz; Raj Padwal; Aletta Elisabeth Schutte; Eoin O'Brien; Daniel T Lackland; Mark L Niebylski; Peter M Nilsson; Kimbree A Redburn; Xin-Hua Zhang; Louise Burrell; Masatsugu Horiuchi; Neil R Poulter; Dorairaj Prabhakaran; Agustin J Ramirez; Ernesto L Schiffrin; Rhian M Touyz; Ji-Guang Wang; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-08       Impact factor: 3.738

4.  A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement.

Authors:  George S Stergiou; Bruce Alpert; Stephan Mieke; Roland Asmar; Neil Atkins; Siegfried Eckert; Gerhard Frick; Bruce Friedman; Thomas Graßl; Tsutomu Ichikawa; John P Ioannidis; Peter Lacy; Richard McManus; Alan Murray; Martin Myers; Paolo Palatini; Gianfranco Parati; David Quinn; Josh Sarkis; Andrew Shennan; Takashi Usuda; Jiguang Wang; Colin O Wu; Eoin O'Brien
Journal:  J Hypertens       Date:  2018-03       Impact factor: 4.844

5.  Validation protocols for blood pressure measuring devices in the 21st century.

Authors:  George S Stergiou; Bruce S Alpert; Stephan Mieke; Jiguang Wang; Eoin O'Brien
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

6.  Validation of the Omron HEM-7201 upper arm blood pressure monitor, for self-measurement in a high-altitude environment, according to the European Society of Hypertension International Protocol revision 2010.

Authors:  K Cho; M Tian; Y Lan; X Zhao; L L Yan
Journal:  J Hum Hypertens       Date:  2013-03-07       Impact factor: 3.012

7.  Number of Measurements Needed to Obtain a Reliable Estimate of Home Blood Pressure: Results From the Improving the Detection of Hypertension Study.

Authors:  Natalie A Bello; Joseph E Schwartz; Ian M Kronish; Suzanne Oparil; D Edmund Anstey; Ying Wei; Ying Kuen K Cheung; Paul Muntner; Daichi Shimbo
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 6.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.